Gemcitabine combined with coinstantaneous radiotherapy for locally advanced pancreatic cancer
10.3760/cma.j.issn.1673-422X.2012.09.023
- VernacularTitle:吉西他滨联合同步放疗治疗局部晚期胰腺癌疗效观察
- Author:
Tieying WU
;
Junqing ZHANG
;
Yonglan LIU
;
Zhenzhong XIAO
;
Yanguo FENG
;
Zhigang WU
;
Xiaolong HAN
- Publication Type:Journal Article
- Keywords:
Pancreatic neoplasms;
Stereotaxic techniques;
Drug therapy,combination
- From:
Journal of International Oncology
2012;39(9):717-720
- CountryChina
- Language:Chinese
-
Abstract:
ObjectiveTo evaluate the efficacy of stereotactic body radiotherapy combined with coinstan taneous gemcitabine,and gemcitabine alone for advanced pancreatic cancer.Methods56 advanced pancreatic cancer patients were assigned into observation group,which accepted stereotactic body radiotherapy combined with coinstantaneous gemcitabine 500 mg/m2,d1,d8.Other 50 patients were assigned into the control group which only accepted gemcitabine 1 000 mg/m2,d1,d8,d15.Stereotactic body radiotherapy was delivered with a total dose of 4 000-4 500 cGy in 10 fractions.ResultsCT examinations were carried out 2 months after treatment.The response rate of the observation group and control group was 82％ and 16％ respectively,and the pain relief rate was 67％ and 17％ respectively.The time to progression of the observation group was 14 months,and was better than that of the control group(7.5 months,x2 =7.31,P =0.032).The median survival time of the observation group and control group was 15.8 months and 13.2 months,and the difference had no statistical significance(x2 =3.28,P =0.082).ConcolusionStereotactic body radiotherapy combined with gemcitabine has a better overall response rate and a pain relief rate.It can prolong the time to progression,but can't improve the overall survival.
